Merck & Company, Inc. News Headlines

MRK 
$55.13
*  
1.08
2%
Get MRK Alerts
*Delayed - data as of Oct. 21, 2014  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    MRK After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Notable Two Hundred Day Moving Average Cross - MRK
10/13/2014 4:01:53 PM - BNK Invest


Dow Movers: MRK, TRV
10/13/2014 1:43:41 PM - BNK Invest


A Quick Look at Merck & Co. Inc.'s Drug Development Pipeline
10/13/2014 12:41:02 PM - Motley Fool


Gilead Sciences Inc. Gets First Hepatitis C Cocktail Drug Approved
10/10/2014 5:18:02 PM - Motley Fool


Merck Becomes #21 Most Shorted Dow Stock, Replacing Chevron
10/10/2014 9:36:58 AM - BNK Invest


iShares U.S. Healthcare ETF Experiences Big Inflow
10/9/2014 11:05:17 AM - BNK Invest


Why companies like BAE and Bayer issued debt in US markets
10/9/2014 9:00:00 AM - Market Realist


Weighting Your Dividend Growth Stocks
10/9/2014 8:13:00 AM - Seeking Alpha


Bristol Myers Squibb Getting Close To Lung Cancer Approval For Nivolumab
10/8/2014 1:52:49 PM - Trefis


Dow Movers: DD, MRK
10/8/2014 11:42:14 AM - BNK Invest


Bristol-Myers Tells Gilead Sciences, Inc. "You Win"
10/8/2014 11:05:02 AM - Motley Fool


Called Strike 3 For Bristol-Myers Squibb: What This Says For Gilead And Its Competitors In The Hep C Market
10/8/2014 10:51:00 AM - Seeking Alpha


Should Pfizer Inc. Buy This Surprisingly Competitive Biotech Stock?
10/7/2014 8:30:16 AM - Motley Fool


HCV: The 'C' Stands For Cure
10/7/2014 1:31:00 AM - Seeking Alpha


Merck Prices EUR 2.5 Bln Debt Offering
10/6/2014 1:04:00 PM - RTT News


Comparing America's 3 Largest Drug Manufacturers
10/6/2014 11:53:00 AM - Seeking Alpha


Gilead Sciences, Inc. Got 2 Drugs Approved, and Didn't Bother to Tell Anyone
10/4/2014 12:45:02 PM - Motley Fool


Better Dividend Stock: Merck & Co. Inc. or Bristol-Myers Squibb Co.?
10/4/2014 12:14:03 PM - Motley Fool


Lung Cancer Incidence Is the Highest in These 10 States
10/4/2014 10:12:02 AM - Motley Fool


There's a Powerful Case for Better Corporate Political Disclosure
10/4/2014 8:26:02 AM - Motley Fool


How Significant Can Keytruda Be For Merck?
10/3/2014 3:57:00 PM - Seeking Alpha


Dow Movers: XOM, DIS
10/3/2014 12:35:54 PM - BNK Invest


The Question Isn't If Gilead's Hep C Combo Will Be Approved In The US By Next Friday; The Question Is The Price Of The Regimen
10/3/2014 12:12:00 PM - Seeking Alpha


Achillion: Positioned To Deliver The Last Clinical Stage Nuc To The Highest Bidder
10/2/2014 2:48:00 PM - Seeking Alpha


Ligand Earns Milestone Payment on EU Approval of Noxafil - Analyst Blog
10/2/2014 1:00:00 PM - Zacks.com